Neumora Therapeutics, Inc.

11.90 USD
+0.11 (+0.93%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Neumora Therapeutics, Inc. stock is up 4.29% since 30 days ago. The next earnings date is Feb 15, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 0% of the previous 1 December’s closed higher than November. 100% of analysts rate it a buy.

About Neumora Therapeutics, Inc.

We are a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. Our principal executive offices are located at 490 Arsenal Way, Suite 200, Watertown, Massachusetts.